8 Results for "

human glutaminyl cyclase

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "human glutaminyl cyclase" in MCE Product Catalog:

Cat. No.: HY-119173
CAS No.: 790663-33-1
Purity:  99.53%
Target:  

Amyloid-β

Research Areas:  

Neurological Disease

PBD-150 is a human glutaminyl cyclase (hQC) Y115E-Y117E variant inhibitor, with a Ki value of 490 nM .
loading...
    loading...
Cat. No.: HY-N7653
CAS No.: 529-51-1
Azaleatin is an orally active inhibitor of hQC, NS2B-NS3 protease and E. coli β-glucuronidase, with IC50 values of 1.1 μM, 38.00 μg/mL and 0.57 μM, respectively. Azaleatin inhibits the activities of NF-κB, MyD88, JAK1, TLR4, STAT3, IL-1β, IL-6, COX-2, TNF-α and β-glucuronidase, blocks pro-inflammatory signaling pathways, reduces the levels of ROS, MDA and uric acid, elevates the levels of GPx, GSR, GST, SOD, CAT, HO-1 and GSH, scavenges free radicals and exerts reducing capacity. Azaleatin inhibits the expression of pro-apoptotic proteins Bax, Caspase-9 and Caspase-3, and upregulates the expression of anti-apoptotic protein Bcl-2. Azaleatin reduces the levels of cardiac injury markers, restores cardiac histological structure, inhibits aggregation, dengue protease activity, hepatic stellate cell proliferation and cancer cell growth, and also exhibits antibacterial activity. Azaleatin can be used in studies related to subchronic cardiotoxicity, Alzheimer's disease, dengue fever, hyperuricemia, liver fibrosis, gastric cancer and bacterial infections .
loading...
    loading...
Cat. No.: HY-151132
CAS No.: 3032400-33-9
Purity:  98.21%
Synonyms: IsoQC-IN-1
Target:  

CD47

Research Areas:  

Cancer

Glutaminyl cyclases-IN-1 (IsoQC-IN-1) is a potent glutaminyl cyclases (QC) inhibitor with IC50 values of 12 nM and 73 nM for human QC and isoQC, respectively. Glutaminyl cyclases-IN-1 can selectively interfere with the interaction of CD47/SIRPα through isoQC inhibition, and enhances the increased phagocytic activity of both THP-1 and U937 macrophages .
loading...
    loading...
Cat. No.: HY-152031
CAS No.: 3033553-63-5
Target:  

Amyloid-β

Research Areas:  

Neurological Disease

Glutaminyl Cyclase Inhibitor 5 (Compound 71) is a potent and selective human glutaminyl cyclase (hQC) inhibitor with an IC50 of 3.2 nM .
loading...
    loading...
Cat. No.: HY-101282
CAS No.: 2092921-50-9
Target:  

Amyloid-β

Research Areas:  

Neurological Disease

Glutaminyl Cyclase Inhibitor 3 (compound 212 ), a designed anti-Alzheimer’s compound, is a potent human Glutaminyl Cyclase (GC) inhibitor, with an IC50 of 4.5 nM. Glutaminyl Cyclase-IN-1 (compound 212) significantly reduced the brain concentrations of pyroform Aβ and total Aβ and restored cognitive functions .
loading...
    loading...
Cat. No.: HY-181797
Target:  

Amyloid-β CD47

Research Areas:  

Cancer

CL121 is a Glutaminyl Cyclase inhibitor with an IC50 of 0.07 μM against human sQC and an IC50 of 0.54 μM against human gQC. CL121 reduces the level of pyroglutamate (pE)-modified CD47 on the surface of cancer cells. CL121 exhibits anti-tumor activity against triple-negative breast cancer .
loading...
    loading...
Cat. No.: HY-P76560
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: QPCT; GCT; glutaminyl-Peptide Cyclotransferase; Glutamyl cyclase; glutaminyl cyclase; SQC; QC; EC; glutaminyl-TRNA Cyclotransferase
Species:  
Human
Source:  
Sf9 insect cells
loading...
    loading...
Cat. No.: HY-187205
CAS No.: 3105939-80-5
Research Areas:  

Neurological Disease

Glutaminyl cyclase/CB2R modulator-1 (Compound 18) acts as an inhibitor of glutaminyl cyclase (QC) (IC50 = 0.65 μM) and an agonist of cannabinoid receptor type 2 (CB2R) (EC50 = 0.32 μM). Glutaminyl cyclase/CB2R modulator-1 can be used for the research of Alzheimer's disease .
loading...
    loading...